Morning Watch List: Kandi Technolgies (NASDAQ:KNDI), QUALCOMM (NASDAQ:QCOM), Teekay Offshore Partners (NYSE:TOO), Flexion Therapeutics (NASDAQ:FLXN), Avon Products Inc. (NYSE:AVP)

On July 30,2014 Kandi Technologies Group, Inc. (Nasdaq:KNDI), announced that, due to the high demand for EV charging and parking facilities in Hangzhou city, Zhejiang province in China, on-street EV charging/parking stations have been added to the Hangzhou Car-Share Program network to meet the needs of the Car-Share Program participants.  Kandi Technolgies Group, Inc. (NASDAQ:KNDI) belongs to Consumer Goods sector. Its net profit margin is -29.40% and weekly performance is -8.36%. On last trading day company shares ended up $17.21. Kandi Technolgies Group, Inc. (NASDAQ:KNDI) distance from 50-day simple moving average (SMA50) is 11.35%.

QUALCOMM, Inc. (NASDAQ:QCOM) said it donated $325,000 to assist in earthquake relief efforts in China’s Yunnan Province.

Qualcomm has committed the funds to Charities Aid Foundation of America who has made a grant from their fund to the China Youth Development Foundation at the company’s suggestion, Qualcomm said. QUALCOMM, Inc. (NASDAQ:QCOM) shares moved down -0.79% in last trading session and ended the day at $74.14. QCOM Gross Margin is 60.20% and its return on assets is 16.10%. QUALCOMM, Inc. (NASDAQ:QCOM) quarterly performance is -7.27%.

Teekay Offshore Partners L.P. (NYSE:TOO) released its earnings data on Thursday. The company reported $0.17 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.36 by $0.19. On 12 August, Teekay Offshore Partners LP (NYSE:TOO) shares moved down -0.14% and was closed at $34.53. TOO EPS growth in last 5 year was 23.30%. Teekay Offshore Partners LP (NYSE:TOO) year to date (YTD) performance is 9.45%.

Flexion Therapeutics’ (NASDAQ:FLXN) lock-up period will expire on Monday, August 11th. Flexion Therapeutics had issued 5,000,000 shares in its public offering on February 12th. The total size of the offering was $65,000,000 based on an initial share price of $13.00. After the end of the company’s lock-up period, company insiders and major shareholders will be able to sell their shares of the company.Flexion Therapeutics, Inc. (NASDAQ:FLXN) ended the last trading day at $12.96. Company weekly volatility is calculated as 3.00%and price to cash ratio as 2.58. Flexion Therapeutics, Inc. (NASDAQ:FLXN) showed a weekly performance of 3.27%.

Analysts at BMO Capital Markets cut their price target on shares of Avon Products (NYSE:AVP) from $15.00 to $14.00 in a research report issued to clients and investors on Wednesday.Avon Products Inc. (NYSE:AVP) shares moved down -0.22% in last trading session and ended the day on $13.79. AVP Gross Margin is 60.70% and its return on assets is -3.50%. Avon Products Inc. (NYSE:AVP) quarterly performance is 1.85%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone